Profile
Dr. Petter Björquist is a Chief Executive Officer at Verigraft AB and a Chief Executive Officer at NovaHep AB. He is on the Board of Directors at ATMP Sweden, Phase Holographic Imaging AB and Stimuliver ApS.
Dr. Björquist was previously employed as a Vice President-Regenerative Medicine by Takara Bio Europe AB.
Petter Björquist active positions
| Companies | Position | Start |
|---|---|---|
| PHASE HOLOGRAPHIC IMAGING PHI AB | Director/Board Member | - |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services Provides stem-cell research for gene therapy of liver diseases | Chief Executive Officer | - |
Verigraft
Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Chief Executive Officer | 2014-01-31 |
Former positions of Petter Björquist
| Companies | Position | End |
|---|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Corporate Officer/Principal | 2013-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services Provides stem-cell research for gene therapy of liver diseases | Commercial Services |
Phase Holographic Imaging AB
Phase Holographic Imaging AB BiotechnologyHealth Technology Develops and manufactures imaging microscopes and cell analyzers | Health Technology |
Verigraft
Verigraft BiotechnologyHealth Technology Engages in development of personalized human tissues for transplantation | Health Technology |
- Stock Market
- Insiders
- Petter Björquist
















